Spero Therapeutics

We partnered with Elmmly and Agency39a to develop a new website for Spero Therapeutics, a biopharmaceutical company that develops novel treatments for serious infections with a focus on antibiotics. Spero develops therapies that target the underlying mechanisms of bacterial resistance and improve patient outcomes by addressing the growing problem of antibiotic resistance.


Website Development
Agency39A Partnership


Agency39A approached us with their client, Spero Therapeutics, to develop a new website and publication library.


Through our collaboration with Agency39, we successfully developed a new, modern, and visually aesthetic website that accurately represents their refreshed brand and effectively communicates Spero's core message to their target audience.